CD163 and hepatocellular carcinoma: Similarly, soluble CD163 (sCD163), a specific biomarker for M2 macrophage activation, has been reported to play a key role in liver pathogenesis by activating several immunoregulatory pathways and therefore was introduced as a useful tool for assessing the severity of liver damage and predicting HCC [24].